The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 20, 2015
Filed:
Oct. 04, 2013
Applicant:
Purdue Pharma L.p., Stamford, CT (US);
Inventors:
Benjamin Oshlack, New York, NY (US);
Curtis Wright, Norwalk, CT (US);
J.David Haddox, Upper Stepney, CT (US);
Assignee:
Purdue Pharma L.P., Stamford, CT (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 31/485 (2006.01); A61K 9/51 (2006.01); A61K 9/02 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 9/48 (2006.01); A61K 9/50 (2006.01); A61K 9/70 (2006.01);
U.S. Cl.
CPC ...
A61K 9/51 (2013.01); A61K 9/0043 (2013.01); A61K 9/006 (2013.01); A61K 9/02 (2013.01); A61K 9/1617 (2013.01); A61K 9/1635 (2013.01); A61K 9/1647 (2013.01); A61K 9/1694 (2013.01); A61K 9/2077 (2013.01); A61K 9/2081 (2013.01); A61K 9/2866 (2013.01); A61K 9/4808 (2013.01); A61K 9/5031 (2013.01); A61K 9/5078 (2013.01); A61K 9/5084 (2013.01); A61K 9/7053 (2013.01); A61K 9/7061 (2013.01); A61K 9/14 (2013.01); A61K 9/50 (2013.01); A61K 31/485 (2013.01);
Abstract
Disclosed is a substantially non-releasable form of an opioid antagonist containing the opioid antagonist combined with one or more pharmaceutically acceptable hydrophobic material(s) such that the antagonist is not released or substantially not released during its transit through the gastrointestinal tract when administered orally in an intact oral dosage form. Oral dosage forms containing an opioid agonist and a substantially non-releasable form of an opioid antagonist are also disclosed.